Cowen Reiterates “$82.00” Price Target for Core Laboratories (CLB)

Cowen set a $82.00 price target on Core Laboratories (NYSE:CLB) in a report issued on Monday. The brokerage currently has a hold rating on the oil and gas company’s stock.

Other equities analysts have also issued reports about the stock. Piper Jaffray Companies set a $95.00 target price on shares of Core Laboratories and gave the company a hold rating in a report on Friday, October 5th. Bank of America began coverage on shares of Core Laboratories in a report on Wednesday, October 17th. They set a neutral rating for the company. Guggenheim raised shares of Core Laboratories from a neutral rating to a buy rating and set a $120.00 target price for the company in a report on Friday, November 16th. JPMorgan Chase & Co. lifted their target price on shares of Core Laboratories from $118.00 to $121.00 and gave the company an overweight rating in a report on Monday, September 17th. Finally, Morgan Stanley set a $115.00 target price on shares of Core Laboratories and gave the company a hold rating in a report on Thursday, October 11th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $111.42.

CLB opened at $79.54 on Monday. Core Laboratories has a 12-month low of $78.44 and a 12-month high of $130.34. The company has a quick ratio of 1.85, a current ratio of 2.31 and a debt-to-equity ratio of 1.83. The company has a market cap of $3.52 billion, a price-to-earnings ratio of 33.42, a price-to-earnings-growth ratio of 2.51 and a beta of 1.65.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, October 24th. The oil and gas company reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.01. Core Laboratories had a net margin of 13.21% and a return on equity of 68.00%. The company had revenue of $182.15 million during the quarter, compared to analyst estimates of $178.11 million. During the same period last year, the firm posted $0.46 EPS. Core Laboratories’s revenue for the quarter was up 11.8% compared to the same quarter last year. Analysts expect that Core Laboratories will post 2.3 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 20th. Stockholders of record on Friday, October 19th were issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 2.77%. The ex-dividend date of this dividend was Thursday, October 18th. Core Laboratories’s dividend payout ratio (DPR) is 110.00%.

Large investors have recently bought and sold shares of the company. Signaturefd LLC increased its holdings in Core Laboratories by 403.7% in the 2nd quarter. Signaturefd LLC now owns 811 shares of the oil and gas company’s stock worth $102,000 after acquiring an additional 650 shares in the last quarter. Cornerstone Wealth Management LLC purchased a new stake in Core Laboratories in the 3rd quarter worth $122,000. Capital International Inc. CA purchased a new stake in Core Laboratories in the 3rd quarter worth $156,000. Parallel Advisors LLC increased its holdings in Core Laboratories by 73.3% in the 3rd quarter. Parallel Advisors LLC now owns 1,634 shares of the oil and gas company’s stock worth $189,000 after acquiring an additional 691 shares in the last quarter. Finally, WMS Partners LLC purchased a new stake in Core Laboratories in the 2nd quarter worth $202,000.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

See Also: Stock Symbols and CUSIP Explained

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply